Detalles de la búsqueda
1.
Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock.
N Engl J Med
; 390(15): 1382-1393, 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38587239
2.
Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease.
Am J Physiol Gastrointest Liver Physiol
; 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38625142
3.
Long-term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes.
Catheter Cardiovasc Interv
; 103(2): 276-285, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38091338
4.
Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease.
BMC Gastroenterol
; 24(1): 43, 2024 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38262952
5.
Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent.
Catheter Cardiovasc Interv
; 101(1): 13-21, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36378691
6.
Randomized Clinical Comparison of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT X Trial.
Circulation
; 143(22): 2155-2165, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33823606
7.
Influence of fractional flow reserve on grafts patency: Systematic review and patient-level meta-analysis.
Catheter Cardiovasc Interv
; 99(3): 730-735, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34233071
8.
Impact of diabetes on 1-year clinical outcome in patients undergoing revascularization with the BioFreedom stents or the Orsiro stents from the SORT OUT IX trial.
Catheter Cardiovasc Interv
; 99(4): 1095-1103, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35043539
9.
Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent.
Catheter Cardiovasc Interv
; 99(7): 1965-1975, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35384254
10.
Randomized Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent With the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated With Percutaneous Coronary Intervention: The SORT OUT IX Trial.
Circulation
; 141(25): 2052-2063, 2020 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32434381
11.
Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation: The Importance of Stent Size.
Cardiology
; 146(6): 705-712, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34343998
12.
Coronary Artery Healing Process after Bioresorbable Scaffold in Patients with Non-ST-Segment Elevation Myocardial Infarction: Rationale, Design, and Methodology of the HONEST Study.
Cardiology
; 146(2): 161-171, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33524985
13.
Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease.
Mol Syst Biol
; 15(3): e8793, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30824564
14.
Rationale and design of DanGer shock: Danish-German cardiogenic shock trial.
Am Heart J
; 214: 60-68, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31176289
15.
Impact of diabetes on clinical outcomes after revascularization with sirolimus-eluting and biolimus-eluting stents with biodegradable polymer from the SORT OUT VII trial.
Catheter Cardiovasc Interv
; 93(4): 567-573, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30244533
16.
Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes.
Am J Physiol Gastrointest Liver Physiol
; 314(1): G91-G96, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28971838
17.
Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver disease.
J Hepatol
; 64(4): 908-15, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26626496
18.
Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial.
Lancet
; 385(9977): 1527-35, 2015 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25601789
19.
Influence of multivessel disease with or without additional revascularization on mortality in patients with ST-segment elevation myocardial infarction.
Am Heart J
; 170(1): 70-8, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26093866
20.
Influence of gastrointestinal factors on glucose metabolism in patients with cirrhosis.
J Gastroenterol Hepatol
; 30(10): 1522-8, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25867498